Go Pro
Luca Issi

Luca Issi Analyst Performance

Senior Biotechnology Analyst at Royal Bank Of Canada

Luca Issi is a stock analyst at Royal Bank Of Canada focused in the healthcare sector, covering 31 publicly traded companies. Over the past year, Luca Issi has issued 62 stock ratings, including buy and hold recommendations. While full access to Luca Issi's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Luca Issi's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
99 Last 1 Years
Buy Recommendations
63.64% 63 Buy Ratings
Companies Covered
31 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy63.6%63 ratings
Hold36.4%36 ratings
Sell0.0%0 ratings

Out of 99 total stock ratings issued by Luca Issi at Royal Bank Of Canada, the majority (63.6%) have been Buy recommendations, followed by 36.4% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
96.8% of companies on NASDAQ
30 companies
NYSE
3.2% of companies on NYSE
1 company

Luca Issi, an analyst at Royal Bank Of Canada, currently covers 31 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
30 companies
96.8%
Energy
1 company
3.2%

Luca Issi of Royal Bank Of Canada specializes in stock coverage within the Healthcare sector, with additional focus on Energy companies.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
29 companies
93.5%
PHARMACEUTICALS
1 company
3.2%
ENERGY EQUIPMENT & SERVICES
1 company
3.2%

Luca Issi's Ratings History at Royal Bank Of Canada

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Solid Biosciences Inc. stock logo
SLDB
Solid Biosciences
9/16/2026Initiated Coverage$8.37$18.00Outperform
Solid Biosciences Inc. stock logo
SLDB
Solid Biosciences
9/16/2026Initiated Coverage$8.72$18.00Outperform
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
9/9/2026Lower Price Target$20.31$30.00Outperform
Ultragenyx Pharmaceutical Inc. stock logo
RARE
Ultragenyx Pharmaceutical
9/3/2026Downgrade$14.85Hold
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
8/31/2026Reiterated Rating$84.91$100.00Outperform
Moderna, Inc. stock logo
MRNA
Moderna
8/19/2026Reiterated Rating$144.21$130.00Sector Perform
argenex SE stock logo
ARGX
argenex
8/18/2026Boost Price Target$987.84$1,100.00Outperform
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
8/14/2026Boost Price Target$247.75$290.00Outperform
Amgen Inc. stock logo
AMGN
Amgen
8/5/2026Boost Price Target$390.63$400.00Outperform
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
7/31/2026Lower Price Target$203.09$350.00Outperform
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
7/30/2026Boost Price Target$25.20$35.00Outperform
argenex SE stock logo
ARGX
argenex
7/24/2026Boost Price Target$919.54$1,025.00Outperform
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
7/13/2026Lower Price Target$56.83$85.00Outperform
Moderna, Inc. stock logo
MRNA
Moderna
7/7/2026Boost Price Target$81.80$45.00Sector Perform
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
7/7/2026Boost Price Target$267.92$280.00Outperform
Agios Pharmaceuticals, Inc. stock logo
AGIO
Agios Pharmaceuticals
7/7/2026Boost Price Target$37.39$32.00Sector Perform
Ultragenyx Pharmaceutical Inc. stock logo
RARE
Ultragenyx Pharmaceutical
7/7/2026Boost Price Target$35.89$40.00Outperform
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
7/7/2026Lower Price Target$59.50$62.00Sector Perform
argenex SE stock logo
ARGX
argenex
7/7/2026Boost Price Target$925.81$945.00Outperform
uniQure N.V. stock logo
QURE
uniQure
6/18/2026Boost Price Target$48.16$65.00Outperform
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
5/8/2026Boost Price Target$74.04$87.00Outperform
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
5/5/2026Reiterated Rating$54.43$66.00Sector Perform
Moderna, Inc. stock logo
MRNA
Moderna
5/4/2026Boost Price Target$46.82$38.00Sector Perform
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
5/1/2026Lower Price Target$300.78$445.00Outperform
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
4/30/2026Boost Price Target$74.76$100.00Outperform
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
4/9/2026Initiated Coverage$74.14$100.00Outperform
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
4/8/2026Upgrade$75.52Moderate Buy
uniQure N.V. stock logo
QURE
uniQure
3/9/2026Upgrade$14.27$35.00Outperform
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
3/3/2026Boost Price Target$14.00$15.00Sector Perform
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
3/2/2026Boost Price Target$242.09$275.00Outperform
uniQure N.V. stock logo
QURE
uniQure
3/2/2026Downgrade$10.37$11.00Sector Perform
argenex SE stock logo
ARGX
argenex
2/27/2026Lower Price Target$773.97$890.00Outperform
uniQure N.V. stock logo
QURE
uniQure
2/26/2026Reiterated Rating$17.11$11.00Sector Perform
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
2/25/2026Reiterated Rating$81.09Outperform
Beam Therapeutics Inc. stock logo
BEAM
Beam Therapeutics
2/25/2026Boost Price Target$32.40$26.00Sector Perform
Moderna, Inc. stock logo
MRNA
Moderna
2/17/2026Boost Price Target$43.20$30.00Sector Perform
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
1/20/2026Boost Price Target$205.83$250.00Outperform
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
1/20/2026Lower Price Target$349.07$465.00Outperform
Moderna, Inc. stock logo
MRNA
Moderna
1/12/2026Reiterated Rating$33.85Sector Perform
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
12/17/2025Boost Price Target$78.37$95.00Outperform
They didn't warn anyone in 1971. This time someone is warning you. (Ad)

On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.tc pixel

Request the free guide in 30 seconds and get positioned now
argenex SE stock logo
ARGX
argenex
12/17/2025Boost Price Target$861.66$925.00Outperform
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
12/11/2025Boost Price Target$70.05$80.00Outperform
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
12/8/2025Upgrade$18.52$27.00Outperform
Fulcrum Therapeutics, Inc. stock logo
FULC
Fulcrum Therapeutics
12/8/2025Boost Price Target$8.90$10.00Sector Perform
Moderna, Inc. stock logo
MRNA
Moderna
11/21/2025Lower Price Target$22.90$25.00Sector Perform
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
11/19/2025Boost Price Target$40.85$52.00Outperform
Agios Pharmaceuticals, Inc. stock logo
AGIO
Agios Pharmaceuticals
11/19/2025Downgrade$22.69$28.00Sector Perform
Korro Bio, Inc. stock logo
KRRO
Korro Bio
11/13/2025Downgrade$31.42Sector Perform
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
11/11/2025Boost Price Target$54.58$50.00Sector Perform
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
11/7/2025Lower Price Target$9.19$9.00Sector Perform
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
11/7/2025Boost Price Target$11.27$19.00Outperform
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
11/6/2025Boost Price Target$17.87$30.00Outperform
uniQure N.V. stock logo
QURE
uniQure
11/3/2025Lower Price Target$34.29$45.00Outperform
argenex SE stock logo
ARGX
argenex
10/31/2025Boost Price Target$816.27$860.00Outperform
Fulcrum Therapeutics, Inc. stock logo
FULC
Fulcrum Therapeutics
10/30/2025Boost Price Target$9.29$7.00Sector Perform
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
10/30/2025Boost Price Target$73.96$82.00Outperform
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
10/28/2025Reiterated Rating$53.68$66.00Sector Perform
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
10/28/2025Reiterated Rating$14.79$14.00Sector Perform
Avidity Biosciences, Inc. stock logo
RNA
Avidity Biosciences
10/28/2025Reiterated Rating$70.00$72.00Sector Perform
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
10/28/2025Downgrade$13.96$14.00Sector Perform
Avidity Biosciences, Inc. stock logo
RNA
Avidity Biosciences
10/28/2025Downgrade$69.93$72.00Sector Perform
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
9/19/2025Boost Price Target$452.17$500.00Outperform
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
9/4/2025Boost Price Target$60.56$80.00Outperform
argenex SE stock logo
ARGX
argenex
8/25/2025Initiated Coverage$660.00$850.00Outperform
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
8/8/2025Lower Price Target$10.72$21.00Outperform
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
8/8/2025Boost Price Target$190.21$230.00Outperform
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
8/8/2025Lower Price Target$16.10$38.00Outperform
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
8/8/2025Lower Price Target$7.82$17.00Outperform
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
8/5/2025Boost Price Target$53.14$42.00Sector Perform
Fulcrum Therapeutics, Inc. stock logo
FULC
Fulcrum Therapeutics
7/30/2025Boost Price Target$6.96$5.00Sector Perform
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
7/29/2025Lower Price Target$8.94$23.00Outperform
Adverum Biotechnologies, Inc. stock logo
ADVM
Adverum Biotechnologies
5/15/2025Lower Price Target$1.91$4.00Sector Perform
Allogene Therapeutics, Inc. stock logo
ALLO
Allogene Therapeutics
5/14/2025Reiterated Rating$0.90$10.00Outperform
Apellis Pharmaceuticals, Inc. stock logo
APLS
Apellis Pharmaceuticals
5/8/2025Lower Price Target$18.14$18.00Sector Perform
Moderna, Inc. stock logo
MRNA
Moderna
5/2/2025Lower Price Target$27.54$28.00Sector Perform
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
4/16/2025Initiated Coverage$153.92$205.00Outperform
Adverum Biotechnologies, Inc. stock logo
ADVM
Adverum Biotechnologies
4/16/2025Lower Price Target$3.20$5.00Sector Perform
Lexeo Therapeutics, Inc. stock logo
LXEO
Lexeo Therapeutics
3/25/2025Lower Price Target$3.88$20.00Outperform
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
3/21/2025Boost Price Target$281.35$330.00Outperform
Korro Bio, Inc. stock logo
KRRO
Korro Bio
3/19/2025Lower Price Target$24.13$95.00Outperform
Ocular Therapeutix, Inc. stock logo
OCUL
Ocular Therapeutix
3/18/2025Initiated Coverage$7.94$17.00Outperform
Sangamo Therapeutics, Inc. stock logo
SGMO
Sangamo Therapeutics
3/18/2025Reiterated Rating$0.86$2.00Sector Perform
MeiraGTx Holdings PLC stock logo
MGTX
MeiraGTx
3/17/2025Boost Price Target$7.77$13.00Outperform
Allogene Therapeutics, Inc. stock logo
ALLO
Allogene Therapeutics
3/14/2025Reiterated Rating$1.90$10.00Outperform
4D Molecular Therapeutics, Inc. stock logo
FDMT
4D Molecular Therapeutics
3/3/2025Lower Price Target$4.47$35.00Outperform
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
2/26/2025Reiterated Rating$249.62$310.00Outperform
Beam Therapeutics Inc. stock logo
BEAM
Beam Therapeutics
2/26/2025Boost Price Target$28.85$26.00Sector Perform
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
2/20/2025Reiterated Rating$68.99$70.00Sector Perform
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
2/20/2025Reiterated Rating$32.26$70.00Outperform
Moderna, Inc. stock logo
MRNA
Moderna
2/18/2025Reiterated Rating$35.72$40.00Sector Perform
Ready to give options a try? Your first trade (Ticker included) -INSIDE (Ad)

Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.tc pixel

CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
2/12/2025Lower Price Target$42.75$48.00Sector Perform
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
2/11/2025Reiterated Rating$18.56$42.00Outperform
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
2/11/2025Reiterated Rating$269.35$300.00Outperform
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
1/21/2025Reiterated Rating$7.39$30.00Outperform
Lexeo Therapeutics, Inc. stock logo
LXEO
Lexeo Therapeutics
1/21/2025Reiterated Rating$4.93$24.00Outperform
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
1/21/2025Reiterated Rating$257.98$300.00Outperform
uniQure N.V. stock logo
QURE
uniQure
1/21/2025Reiterated Rating$14.50$24.00Outperform
SLB Limited stock logo
SLB
SLB
1/21/2025Reiterated Rating$44.09$57.00Outperform
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
1/15/2025Reiterated Rating$33.69$70.00Outperform